virtual docker (mvd) version 7.0.0 software (Molegro ApS)
90
Structured Review
Molegro ApS
virtual docker (mvd) version 7.0.0 software
Virtual Docker (Mvd) Version 7.0.0 Software, supplied by Molegro ApS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/virtual+docker+software/virtual+docker+mvd+2019+7+0/pm40424842-109-1-0
Average 90 stars, based on 1 article reviews
Virtual Docker (Mvd) Version 7.0.0 Software, supplied by Molegro ApS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/virtual+docker+software/virtual+docker+mvd+2019+7+0/pm40424842-109-1-0
Average 90 stars, based on 1 article reviews
virtual docker (mvd) version 7.0.0 software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Experimental Spectroscopic and Computational Studies on A New Synthesized Sulfisoxazole Derivative; Molecular Docking, Drug-likeness, ADME, Toxicity Predictions and Carbonic Anhydrase II Activity Investigations Article Snippet: The Article Title: Computational Screening of IL-1 and IL-6 Inhibitors for Rheumatoid Arthritis: Insights from Molecular Docking and Dynamics Analysis. Article Snippet: Background: Rheumatoid arthritis (RA) remains a significant therapeutic challenge due to its chronic inflammatory nature.. Consequently, many patients turn to alternative therapies, such as herbal compounds and supplements, when conventional treatments prove relatively ineffective or cause adverse side effects.. Some compounds are being investigated for their potential to alleviate RA symptoms or manage disease. Article Title: In Silico Discovery of Multi-Target Natural Ligands and Efficient siRNA Design for Overcoming Drug Resistance in Breast Cancer via Local Therapy Article Snippet: Article Title: Design and synthesis of novel 3,7-dihydro-1H-purine-2,6-diones as DPP-4 inhibitors: An in silico, in vitro and in vivo approach. Article Snippet: The inhibition of enzyme DPP-4 is pivotal for targeting type 2 diabetes mellitus (DM).. The study introduces two series of novel 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-diones derivatives (PB01-PB10) and 3,7-dihydro-1Hpurine-2,6-diones compounds (PB11-PB16) were developed using linagliptin scaffold.. Sixteen derivatives were synthesized and screened in vitro against DPP-4, revealing IC50 ranging from 15.66 ± 2.546 to 28.45 ± 4.441 nM. Article Title: In silico discovery of multi-target small molecules and efficient siRNA design to overcome drug resistance in breast cancer via local therapy. Article Snippet: In this study, we designed an efficient siRNA for PKMYT1 gene knockdown and evaluated the binding affinity of various natural small molecules to key proteins associated with breast cancer through molecular docking and molecular dynamics (MD) simulations.. Subsequently, among these molecules, The small molecule, SCHEMBL7562664, was introduced as a “golden ligand” that showed potent multi-target activity as an antagonist for aromatase, estrogen receptor α, HER2, and PARP10, and as an agonist for MT2 and STING.. Next, MD simulations of six proteingolden ligand complexes (PDB IDs: 4QXQ, 5GS4, 5JL6, 5LX6, 6ME6, and 7PCD), performed with GROMACS over 100 ns at 298.15 K, provided valuable information about their structural dynamics. Binding Assay:Article Title: In Silico and In Vivo Evaluation of Novel 2-Aminobenzothiazole Derivative Compounds as Antidiabetic Agents. Article Snippet: .. Molecular docking analysis was performed by Molegro |